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induced allergic reactions via regulatory
T cells in mice
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Abstract
Background: Cystic echinococcosis (CE), caused by infection with Echinococcus granulosus larvae, is a potentially
life-threatening disease in humans. Anaphylactic shock caused by CE is very dangerous, and is highly prevalent
during surgery. Dexamethasone (DEX) is used clinically before operations to prevent allergic reactions; Regulatory
T cells (Treg cells) are believed to be associated with negative immune response, which play an important role in
alleviating allergic reactions. However, the association of Treg cells with DEX remains unknown.
Methods: In this study, C57BL/6 mice were divided into uninfected group, untreated group and DEX group which
were inoculated with protoscoleces from E. granulosus and sensitized using a cyst fluid suspension to induce
anaphylactic shock. In addition, the mice in DEX group were treated with 10 mg/kg DEX by intraperitoneal
injection 30 min before being sensitized.
Results: It was found that 93.75 % of all sensitized mice experienced allergic symptoms. The levels of IgE, IgE/IgG,
and IgE/IgG1 were significantly higher in both untreated group and DEX group. The proportion of CD4 + CD25 +
FOXP3 + Treg cells relative to CD4+ Treg cells, and the levels of interleukin-10 (IL-10) and tumor growth factor-β
(TGF-β1) were significantly higher in DEX group. The level of IL-13 was significantly higher in the sensitized mice
than in the other groups. These cells may play a key role in alleviating the immune response in CE-induced
anaphylactic shock.
Conclusions: The protective effect of DEX may be due to Treg cell upregulating IL-10 and TGF-β1 levels, and
inhibiting helper T cell 2 cytokines.
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Background
Cystic echinococcosis (CE), or hydatid disease, is a wide-
spread chronic endemic helminthic disease, commonly
caused by infection with metacestodes (larval stages) of
the tapeworm Echinococcus granulosus (E. granulosus)
[1–3]. At beginning, few clinical symptoms are noticed.
Until hydatid cysts of E. granulosus begins to grow big,
oppression symptom such as abdominal distension and
pain may happen. Sometimes, the hydatid cyst rupture
spontaneous or provoked by external pressure in acci-
dent which will produce lethal effects [4]. The most re-
cent data shows that the intra-operative incidence of
anaphylactic shock is approximately 2 % in CE patients
in China [5].
CE-induced anaphylactic shock is a type I allergy
synergized by endotoxin shock. Patients usually have se-
vere clinical symptoms, long-lasting hypotension, poor
response to vasoactive drugs, and high mortality [6],
which are different with the traditional type I allergy.
Patient needs long-time positive vasoactive agent infu-
sion, which leads to more adverse effects. Thus, elucidat-
ing the mechanism underlying echinococcosis-induced
sensitization is crucial for the development of effective
prevention and treatment protocols for these patients.
Previous studies [7–10] find that, the Th2 response is
the prevalent response in subjects with atopy and some
allergic disease. With the growth of parasite, helper T
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cell 2 (Th2) cell responses and some cytokine profiles
have more benefit effect to protect host against hel-
minthic infections. On the contrary, the helper T cell 1
(Th1) responses are more likely to occur secondary to
specific microbiologic insult. Recent research [11] has
shown that T cells are activated after CE infection, but
the significant increase in the level of Treg cells could
inhibit T cell response to E. granulosus antigens, suggest-
ing that these cells may play a key role in the downregu-
lation of the immune response in CE infection. This
indicates that Treg cells play an important role in para-
site persistence during chronic echinococcosis to main-
tain the immune stable status.
Immune system is a complex regulatory net. Allergy,
tolerance, and active suppression may not be independ-
ent events, but rather involve similar mechanisms. In
some special condition, Treg cells may redirect an in-
appropriate immune response against allergens. Original
tolerance status may change, allergy happen. Induction
of allergen-specific Treg cells seems essential for main-
taining a healthy immune response towards allergens
[12, 13]. In CE infection, the parasites and the host co-
exist in a state of balance for a long time, but the bal-
ance is broken when hydatid cysts rupture, causing a se-
vere allergic reaction. Currently, there are no suitable
methods for preventing the occurrence of anaphylactic
shock caused by CE. Dexamethasone (DEX) is used clin-
ically before operations to prevent allergic reactions.
DEX has a broad-spectrum anti-inflammatory allergy ef-
fect [14], mainly depending on reducing inflammation
factors, but does DEX really work, and if it does, what is
its mechanism of action? Relatively, little information is
available regarding host immune responses following
CE-induced anaphylactic reaction, and therefore little in-
formation is available regarding the nature of these re-
sponses. Illustrating the characteristics of these immune
cells will help the development of new strategies for the
treatment and prevention of anaphylactic reactions.
In this study, we investigated several immune cell pop-
ulations in mice that were either healthy or challenged
with E. granulosus after infection. The objective is to
clarify the changes in the host immune responses during
allergic reaction status, and determine the effectiveness




Forty female C57BL/6 mice weighing 22–25 g (aged 5–7
weeks) were provided by the Animal Center of the First
Affiliated Hospital of Xinjiang Medical University.
Standard guidelines for laboratory animal care (Institute
of Laboratory Animal Resources, Commission on Life
Sciences, National Research Council, 1996) were
followed. All mice were provided with water and stand-
ard chow pellets ad libitum for 2 weeks prior to the start
of the experiment. This study was carried out in strict
accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institutes of Health. The study protocol was reviewed
and approved by the Institutional Animal Ethics Com-
mittee of Xinjiang Medical University.
Preparation of antigen and protoscolex
According to the previous study [15], sheep-derived E.
granulosus cyst fluid (sheep hydatid fluid, SHF) and pro-
toscolex were separated from the livers of sheep infected
with E. granulosus under aseptic conditions. After pre-
cipitation, the supernatant of cyst fluid was obtained.
The protoscolexes in the precipitate were washed with
normal saline containing 1000 U/ml penicillin and
streptomycin for 3–4 times. A dye exclusion test [16]
confirmed that the activity of protoscolexes was > 90 %.
After resuspension of protoscolexes with normal saline
(10000/mL), the supernatant was used as a sensitizing
antigen. Bio-Rad protein assay (Bio-Rad, Richmond, CA,
USA) determined that the total protein content was
2841.331 μg/ml.
The level of endotoxin contamination in SHF was de-
termined to be 0.03 endotoxin unit (EU)/ml by quantita-
tive chromogenic Limulus amebocyte lysate assay
(BioWhittaker Inc., MD, USA). The lipopolysaccharide
(LPS) was tested using a commercially available chromo-
genic LAL end-point assay kit (Cambrex Inc., IA, USA).
The level of LPS in SHF was below 1.2 EU/mg protein.
The supernatant was stored at −80 °C, and then at 4 °C
for 24 h before sensitization.
Animal grouping and E. granulosus infection model
establishing
Forty female C57BL/6 (aged 6–8 weeks) mice were ran-
domly divided into uninfected group (n = 8) and infected
groups (n = 32). In the infected groups, all the mice were
injected percutaneously with 2000 protoscoleces from E.
granulosus. After 3 months, the presence of cysts in the
peritoneal cavity was confirmed by B-scan ultrasonog-
raphy. Sixteen CE-infected mice were randomized into
untreated group and DEX group (n = 8) and the
sensitization was induced by intraperitoneally injecting
SHF with dose of 0.1 ml/10 g [17, 18]. The uninfected
group received phosphate-buffered saline instead of SHF
antigens. The DEX group was treated with 10 mg/kg
DEX (Sigma-Aldrich Corp., MO, USA) by intraperito-
neal injection 30 min before challenging.
Determination of allergy
According to previous study [19], the allergy symptoms
were evaluated every 5 min after sensitization. The
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symptom score scale for horse serum-induced ana-
phylactic shock and the rectal temperature were mea-
sured. The mild allergy was characterized by a ≤ 2 °C
reduction in rectal temperature. The severe allergy
was characterized by a shock state in which the rectal
temperature was reduced by ≥ 5 °C (35.6–30.1 °C).
Symptoms were observed within 60 min after
sensitization and the severity of sensitivity was classi-
fied as mild, moderate, or severe. Mice were sacrificed
at 60 min after sensitization.
Sample preparation
Mice were euthanized by CO2 asphyxiation, and
treated by cervical dislocation. The blood was col-
lected, and then treated with anticoagulant coagulant
for 4 h. After centrifuging at 352 × g for 15 min, the
supernatant was obtained, and stored at −80 °C for
use. The E. granulosus infection was observed by
laparotomy. The lymph nodes from the neck, armpit,
and groin were collected, and then placed in RPMI
1640 (Life Technologies Inc., CA, USA) for flow cy-
tometry. At the same time, half of the left lung was
collected for immunohistochemistry.
Flow cytometry
The immune cells isolated from the mouse lymph
nodes were analyzed by flow cytometry. The lymph
node cells were harvested from all three groups. The
cell suspensions were prepared in complete RPMI
1640. The nonspecific binding sites were blocked for
30 min at 4 °C using ice-cold phosphate-buffered sa-
line supplemented with 1 % normal rat serum. After
extensive washing, the cells were stained using CD4 +
CD25 + FOXP3+ antibodies according to the protocol
provided with the Mouse Regulatory T Cell Staining
Kit (eBioscience Inc., CA, USA). The stained cells
were analyzed by using a FACS-LSRII flow cytometer
(BD Biosciences Inc., CA, USA). The data were ana-
lyzed using FCS Express (De Novo Software; De Novo
Inc., CA, USA).
To evaluate the effectiveness of DEX, regulatory T
cells in experimental allergic mice and the percentage of
CD4 + CD25 + FOXP3+ regulatory T cells among the
CD4+ T cells were analyzed in the lymph nodes of mice
from all groups according to the manufacturer’s protocol
(BD Biosciences Inc., CA, USA). The prepared cells were
stained with anti-mouse CD4 FITC and anti-mouse
CD25 APC, then fixed and permeabilized using the
Foxp3 Staining Buffer Set (eBioscience Inc., CA, USA),
and subsequently stained with 0.5 g of anti-mouse Foxp3
PE (Shanghai Sangon Biological Engineering Co., Ltd.,
Shanghai, China). Cells in the lymphocyte gate were ana-
lyzed using a FACSCalibur cytometer equipped with
CellQuest (BD Biosciences Inc., CA, USA).
Measurement of IgE, IgG, IgG1 and cytokines
Blood samples were taken from the angular vein in eye-
ball of mice, and then quickly placed in anticoagulant
tubes, followed by storing at room temperature for 2 h.
The samples were centrifuged at 352 x g for 10 min, and
then the levels of IgE, IgG, IgG1 and cytokines (IL-10,
IL-13, and TGF-β1) in serum were quantified by
enzyme-linked immunosorbent assay (Eb Inc., Georgia,
USA) according to the manufacturer’s instruction. The
optical density was read at 450 nm.
Immunohistochemistry
The 2-μm thick paraffin sections of left lung were pre-
pared. The sections were deparaffinized, and then
washed with distilled water. After soaking in PBS for
5 min, they were incubated with 3 % H2O2 at room
temperature for 15 min. After washing with PBS, the
sections were incubated with antibodies specific to hista-
mine (1: 500; Sigma-Aldrich Corp., MO, USA) at 4 °C
overnight, followed by washing with PBS. Then the sec-
tions were subsequently incubated with secondary anti-
body at 37 °C for 30 min. After washing with PBS, the
DAB staining was performed, followed by flushing with
water, restaining, dehydration and mounting. The sec-
tions were observed in Q550CW image acquisition and
analysis system (Leica Science Lab, Berlin, Germany).
Positive areas of histamine expression, as indicated by
the detection of brown granules, were selected. Three
positive areas were randomly selected from each section
and the integrated optical density was calculated.
Statistical analysis
All statistical analysis was carried out using SPSS17.0
software (SPSS Inc., Chicago, IL, USA). Data were pre-
sented as mean ± SD. Differences between the groups
were assessed using a one-way ANOVA test with a post-
hoc Bonferroni test for pairwise comparisons if the data
followed a normal distribution or the Kruskal–Wallis
test with a Mann–Whitney U test for pairwise compari-
sons if the data did not follow a normal distribution. P <
0.05 was considered as statistically significant.
Results
Model of CE infection and sensitization
The mean body weight was similar in all three groups
(P = 0.302) (Table 1). CE-infected model were con-
firmed by abdominal ultrasonography and laparotomy.
Only 20 of the 32 (62.5 %) vaccinated mice were suc-
cessfully infected. Several botryoid cysts were found
in each mouse with a minimum diameter of 1 mm
and a maximum diameter of 3 mm. 16 CE-infected
mice were randomized into untreated group and DEX
group (n = 8 in each group).
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Allergy score and rectal temperature were used to de-
termine the linical symptoms of sensitization (Fig. 1), as
well as the levels of lung histamine and serum IgE
(Figs. 2 and 3). It was found that 93.75 % of all sensitized
mice developed allergic symptoms. Only one mouse in
DEX group showed no symptoms of allergy, five pre-
sented with mild allergy, one with moderate allergy, and
one with severe allergy. In untreated group, five mice ex-
hibited mild allergy and three exhibited severe allergy;
the allergy severity for uninfected group was not
assessed.
The clinical symptoms after challenge were shown in
Fig. 1a. Most mice starting with continuous mouth-
scratching and ear canal digging with hind legs (score 1/
5), and the symptoms rapidly progressed to puffiness
around eyes and/or mouth and self-isolation (score 2/5).
The most severe reactions provoked no response to
prodding, tremor, and death. The kinetics and severity of
the anaphylactic reactions were consistent among mice.
The changes in rectal temperature with time with se-
verity of the allergic reaction were shown in Fig. 1b. The
rectal temperature in the uninfected group remained
stable. The mice with a mild allergic reaction experi-
enced a small variation in rectal temperature of less than
2.0 °C; however, the variation in the rectal temperature
in the severe allergy mice was larger at more than 5 °C.
In most of the mice, the rectal temperature began to
change 5 min after sensitization. Anaphylactic shock oc-
curred approximately 40 min later and the mice were
then sacrificed.
Figure 2 presented the levels of antigen-specific
antibody in serum. After infected,the levels of IgE,
IgG, and IgG1 were significantly higher (P < 0.001).
However, the IgE level was significantly lower in DEX
group than that in untreated group (P < 0.001)
(Fig. 2a–c). The ratio of IgE/IgG and IgE/IgG1 dis-
played a similar trend compared to that observed
with the IgE level (Fig. 2d, e).
Histamine levels
Pulmonary histamine levels were determined by im-
munohistochemical analysis and representative images
are shown in Fig. 3a–c. Mice in uninfected group
expressed almost no histamine, but histamine expres-
sion increased after sensitization. In the DEX group,
histamine expression was reduced compared to that
in uninfected group. The results revealed that treat-
ment with DEX almost eliminated the inflammatory
infiltrate in mice (Fig. 3c).
Detection of lymphocyte populations and serum
cytokine levels
Figure 4 presented the proportion of CD4 + CD25 +
FOXP3+ Treg cells relative to CD4+ Treg cells in the
Table 1 The condition of establishment of animal model
Variables Uninfected group (n = 8) Untreated group (n = 8) DEX group (n = 8) p-value
Body weight 23.61 ± 0.83 23.05 ± 0.56 23.25 ± 0.73 0.302
Severity of allergy, score
None 0 (0 %) 0 (0 %) 1(12.5 %)
Mild 0 (0 %) 5 (62.5 %) 5 (62.5 %)
Moderate 0 (0 %) 0 (0 %) 1 (12.5 %)
Severe 0 (0 %) 3 (37.5 %) 1 (12.5 %)
ND 8(100 %) 0 (0 %) 0 (0 %)
Data were presented as mean ± SD for body weight and n (%) for severity of allergy. Differences among groups were compared using one-way ANOVA test for age ND,
not done
Fig. 1 Induction of anaphylaxis in untreated and DEX treated mice.
Mice inoculated with protoscoleces from E. granulosus and sensitized
using a cyst fluid suspension to induce anaphylactic shock. a, Peak
anaphylactic symptom score of each mouse in different group within
60 min after challenge. b, The different changes of rectal temperature
with time in different severity of allergy
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peripheral lymph nodes and the levels of IL-10, TGF-β1,
and IL-13 in serum at each group. Treg cells were
assessed by flow cytometry, as shown in Fig. 4a. Cyto-
kines, including IL-10 and TGF-β, are crucial for the
maintenance of Treg cells as well as their function and
Foxp3 expression, as shown in Figs. 4b and c. IL-13 on
behalf of Th2 cytokines is shown in Fig. 4d.
The results revealed that the percent of CD4 + CD25
+ FOXP3+ Treg cells relative to CD4+ cells was signifi-
cantly higher in DEX group than those in uninfected
group and untreated group (uninfected group: 12.51 ±
1.68; untreated group: 17.92 ± 1.29; DEX group: 29.3 ±
6.54; both P < 0.0001) (Fig. 4a). The results showed that
DEX group had significantly higher levels of IL-10 and
TGF-β1 than those in uninfected group and untreated
group (all P < 0.001) (Fig. 4b, c). The IL-13 level was sig-
nificantly higher in untreated group than in other groups
(both P < 0.001) (Fig. 4d).
As shown in Fig. 5, the percentage of CD4 + CD25 +
FOXP3+ Treg cells among CD4+ cells in the peripheral
lymph nodes in the DEX group was higher than the per-
centages in the other groups.
Fig. 2 The results of antigen specific antibody in serum, IgE (a), IgG1 (b), IgG (c), ratio of IgE/IgG (d), and ratio of IgE/IgG1 (e) by group.
*, †P < 0.05, **, ††P < 0.01,***, †††P < 0.001, indicate significantly different as compared with group A* and group B†, respectively
Fig. 3 Detection of lung histamine by immunohistochemistry
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Discussion
This study investigated the effect of DEX in CE-induced
allergic reactions, especially the role of CD4 + CD25 +
FOXP3+ Treg cells and some cytokines. C57BL/6 mice
were firstly inoculated with E. granulosus to set up CE-
infected model, then some mice were sensitized with
cystic fluid to set up challenge model. DEX has been
preliminary used. After sensitization, the sensitized CE-
infected mice had higher serum IgE levels and lung his-
tamine expression than that observed in the DEX group
(P < 0.001). Furthermore, the sensitized mice had signifi-
cantly higher IgE/IgG and IgE/IgG1 levels as compared
to those observed in uninfected group and the DEX
group. Moreover, in terms of clinical symptoms, the se-
verity of allergy scores suggests that only 12.5 % of the
mice in the DEX group had a severe allergic reaction;
however, in untreated group, the proportion was as high
as 37.5 %. Treatment with DEX can reduce the severity
of allergic reactions induced by CE.
In addition, the proportion of CD4 + CD25 + FOXP3+
Treg cells relative to CD4+ Treg cells was significantly
higher in the DEX group (P < 0.001); significantly higher
IL-10 and TGF-β1 levels were also noted in this group
(all P < 0.001). In contrast, the IL-13 levels were signifi-
cantly higher in the sensitized mice alone (both P <
0.001). Thus, our study confirmed that the levels of
TGF-β1 and IL-10, as well as the proportion of CD4 +
CD25 + FOXP3+ Treg cells relative to CD4+ Treg cells,
exhibited a similar tendency: they all decreased after
sensitization, but increased after treatment with DEX.
Fig. 4 In mice peripheral lymph nodes, % of CD4 + CD25+ FOXP3+ (Treg cells) (a), and Data were presented as mean ± SD by group. ***, †††P < 0.001,
indicate significantly different as compared with group a* and group b†, respectively. Presents the level of TGF-β1, IL-10, and IL-13, in serum by group.
The results showed that DEX group had significantly higher level of TGF-β1 and IL-10 than uninfected group and untreated group (All P < 0.001) (b, c).
The IL-13 level was significantly higher in untreated group B than the other two groups (both P < 0.001, b)
Fig. 5 Results of flow cytometry. The percentage of CD4 + CD25 + FOXP3+ regulatory T cells among CD4+ T cells in peripheral lymph nodes of
experimental mice in 3 groups
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The T-cell network is considered central to the balance
and prevention of Th1 and/or Th2 diseases. Research
has shown that the proportion of CD4 + CD25 + FOXP3
+ Treg cells relative to CD4+ Treg cells is very import-
ant in allergic disorders and parasitic invasions. Schisto-
soma mansoni infection has been associated with
protection against allergies [20]. The mechanisms under-
lying this association may involve regulatory cells and
cytokines. Our research found that the proportion of
CD4 + CD25 + FOXP3+ Treg cells relative to CD4+ Treg
cells increased after E. granulosus infection was consist-
ent with previous studies [21] and significantly increased
with preliminary treatment with DEX, which suggested
their possible role to contributed to the maintenance of
immune tolerance. However, the proportion of Treg cells
relative to CD4+ cells was reduced in untreaded mice
when allergic reaction happened,just as previously de-
scribed [22]. In the pollen season, the sensitization pa-
tients have lower number of Treg cells than healthy
people [23]. The reduction of Treg cells may induce the
occurrence of asthma; Because DEX, which has a role in
the allergic response, interacts with Treg cells in many
immune reactions and has an effect on the allergic reac-
tion [24] in mouse models of OVA-induced asthma [21,
25], further studies will analyze their role in sensitization
in this model.
Just as proved in previous studies [26–28], Treg cells may
exert their effects via IL-10 and TGF-β which are crucial
for the maintenance and function of Treg cells. Following
preliminary treatment with DEX, our research showed in-
creased level of Treg cells consistent with the greater serum
levels of both IL-10 and TGF-β1, which were significantly
reduced after sensitization. IL-10 may exert anti-allergic ef-
fects via inhibiting macrophage activation and cytotoxicity,
and IL-10 is crucial for maintain immune tolerance for the
better of parasites survival and growth [29]. The increased
TGF-β1 levels after treatment with DEX are consistent with
the results of previous studies [21, 24, 30].
Although the proportion of Treg cells and the serum
levels of IL-10 and TGF-β1 were reduced after
sensitization, the level of IL-13 increased. It is shown in
previous studies [31, 32] that cystic fluid-induced
sensitization is accompanied by increased levels of Th2
cells, which is characterized by increased IL-13 levels. The
allergic reaction is associated with high levels of IgE and
IL-13. Treg cells can suppress the allergic reaction directly
through inhibit Th2 cells [33]. DEX may maintain the im-
mune tolerance, increasing the levels of protective IL-10
and markedly reducing levels of IL-13. The effect of DEX
may be related to the increased FOXP3 expression [34].
Further studies will assess the effects of it.
There were limitations in the present study. First, the
composition of the allergens is complex, the exact fac-
tors in the roughly prepared cystic fluid, which mediate
the sensitization, are not investigated further. We did
not use standard allergen, such as ovalbumin [35], to
induce the allergic reaction. Furthermore, we have only
studied the effect of DEX, but there are many other
kinds of glucocorticoids drugs, e.g., hydrocortisone,
which need further researches. In addition, although the
effect of DEX in allergy in CE shock is investigated, the
mechanism by which the sensitization reduces the Treg
cells and cytokine levels has not been explored, so
further study is needed.
Conclusion
In conclusion, DEX has protective effect on CE-induced
allergic reaction by adjusting Treg cells. This protective
effect may be due to Treg cells upregulating IL-10 and
TGF-β1 levels, and inhibiting helper T cell 2 cytokines.
Further studies should be performed to elucidate the
intrinsic mechanism underlying the drug treatment in
CE-induced anaphylactic reaction.
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